Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Celsius Holdings, Inc.CELH · Entity 3658 | Director | June 14, 2021 | June 15, 2021 |
| Niagen Bioscience, Inc.CDXC · Entity 6146 | Director | June 17, 2021 | June 22, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Celsius Holdings, Inc.
Report date June 14, 2021 · Filed June 15, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-06-14 transaction · row 1
1 source rowRow 1 · 2021-06-14 · Sale · Disposed 150,000 · Balance 0 |
Niagen Bioscience, Inc.
Report date June 17, 2021 · Filed June 22, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.99 · Expires 2031-06-16 | Direct | 20,000 |
Reported balance
After 2021-06-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-17 · Grant · Acquired 20,000 · Balance 20,000 F1: Options vest 100% on June 17, 2022 |
Filing footnotes · ownership attribution and instrument terms
F1: Options vest 100% on June 17, 2022
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2021 Filed Jun 22, 2021 17:27 UTC | Niagen Bioscience, Inc. CDXC · Entity 6146 | GrantStock Options (right to buy) · Derivative | 20,000 | $0.00 Strike: $9.99 | $0.00 |
DisclosureSEC source: 0001628280-21-012674 · wf-form4_162439720955892.xml · derivative · entry 1 LAU Tsz Ho Tony · CIK 0001714259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-16 F1 · derivative.exercise_date: Options vest 100% on June 17, 2022 Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 18:33 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | SaleCommon Stock | 150,000 | $62.50 | $9,375,000.00 |
DisclosureSEC source: 0001829126-21-005123 · ownership.xml · nonDerivative · entry 1 LAU Tsz Ho Tony · CIK 0001714259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| June 01, 2021 Filed Jun 15, 2021 17:57 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,147 | $0.00 Strike: $3.23 | $0.00 |
DisclosureSEC source: 0001829126-21-005115 · ownership.xml · derivative · entry 8 LAU Tsz Ho Tony · CIK 0001714259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,853 Underlying: Common Stock · 3,174 shares Expires 2024-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 15, 2021 17:57 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.48 | $0.00 |
DisclosureSEC source: 0001829126-21-005115 · ownership.xml · derivative · entry 7 LAU Tsz Ho Tony · CIK 0001714259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2022-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 15, 2021 17:57 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | Exercise / conversionStock Option (Right to Buy) · Derivative | 66,666 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001829126-21-005115 · ownership.xml · derivative · entry 6 LAU Tsz Ho Tony · CIK 0001714259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,334 Underlying: Common Stock · 66,666 shares Expires 2023-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 15, 2021 17:57 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | Exercise / conversionStock Option (Right to Buy) · Derivative | 36,666 | $0.00 Strike: $3.73 | $0.00 |
DisclosureSEC source: 0001829126-21-005115 · ownership.xml · derivative · entry 5 LAU Tsz Ho Tony · CIK 0001714259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,334 Underlying: Common Stock · 36,666 shares Expires 2024-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 15, 2021 17:57 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | Tax withholdingCommon Stock | 2,992 | $3.23 | $9,664.16 |
DisclosureSEC source: 0001829126-21-005115 · ownership.xml · nonDerivative · entry 4 LAU Tsz Ho Tony · CIK 0001714259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 F4 · shares: Represents a cashless exercise of outstanding stock options to purchase 3,147 shares of common stock. The reporting person received 2,992 shares of common stock and surrendered 155 shares of common stock underlying the stock option underlying the stock option in payment of the exercise price. Read SEC document |
| June 01, 2021 Filed Jun 15, 2021 17:57 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | Tax withholdingCommon Stock | 47,345 | $3.48 | $164,760.60 |
DisclosureSEC source: 0001829126-21-005115 · ownership.xml · nonDerivative · entry 3 LAU Tsz Ho Tony · CIK 0001714259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,008 F3 · shares: Represents a cashless exercise of outstanding stock options to purchase 50,000 shares of common stock. The reporting person received 47,345 shares of common stock and surrendered 2,655 shares of common stock underlying the stock option underlying the stock option in payment of the exercise price. Read SEC document |
| June 01, 2021 Filed Jun 15, 2021 17:57 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | Tax withholdingCommon Stock | 61,987 | $4.60 | $285,140.20 |
DisclosureSEC source: 0001829126-21-005115 · ownership.xml · nonDerivative · entry 2 LAU Tsz Ho Tony · CIK 0001714259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,663 F2 · shares: Represents a cashless exercise of outstanding stock options to purchase 66,666 shares of common stock. The reporting person received 61,987 shares of common stock and surrendered 4,679 shares of common stock underlying the stock option underlying the stock option in payment of the exercise price. Read SEC document |
| June 01, 2021 Filed Jun 15, 2021 17:57 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | Tax withholdingCommon Stock | 34,579 | $3.73 | $128,979.67 |
DisclosureSEC source: 0001829126-21-005115 · ownership.xml · nonDerivative · entry 1 LAU Tsz Ho Tony · CIK 0001714259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,676 F1 · shares: Represents a cashless exercise of outstanding stock options to purchase 36,666 shares of common stock. The reporting person received 34,579 shares of common stock and surrendered 2,087 shares of common stock underlying the stock option underlying the stock option in payment of the exercise price. Read SEC document |
| June 19, 2020 Filed Jun 22, 2020 21:17 UTC | Niagen Bioscience, Inc. CDXC · Entity 6146 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $4.67 | $0.00 |
DisclosureSEC source: 0001415889-20-001663 · form4-06222020_060626.xml · derivative · entry 1 LAU Tsz Ho Tony · CIK 0001714259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-06-18 F1 · derivative.exercise_date: Options vest 100% on June 19, 2021. Read SEC document |
| October 23, 2019 Filed Jul 1, 2020 12:45 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.23 | $0.00 |
DisclosureSEC source: 0001415889-20-001758 · form4-07012020_090722.xml · derivative · entry 2 LAU Tsz Ho Tony · CIK 0001714259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 50,000 shares Expires 2024-10-23 F2 · derivative.exercise_date: The stock options vest in three equal annual installments beginning on October 23, 2020. F3 · derivative.expiration_date: The stock options vest in three equal annual installments beginning on October 23, 2020. Read SEC document |
| June 21, 2019 Filed Jun 24, 2019 20:42 UTC | Niagen Bioscience, Inc. CDXC · Entity 6146 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.80 | $0.00 |
DisclosureSEC source: 0001415889-19-000800 · form4-06242019_050604.xml · derivative · entry 1 LAU Tsz Ho Tony · CIK 0001714259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-06-21 F1 · derivative.exercise_date: Options vest 100% on June 21, 2020. Read SEC document |
| January 24, 2019 Filed Jul 1, 2020 12:45 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.73 | $0.00 |
DisclosureSEC source: 0001415889-20-001758 · form4-07012020_090722.xml · derivative · entry 1 LAU Tsz Ho Tony · CIK 0001714259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 50,000 shares Expires 2024-01-24 F1 · derivative.exercise_date: The stock options vest in three equal annual installments beginning on January 24, 2020. Read SEC document |
| July 26, 2018 Filed Aug 3, 2018 14:57 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001714259-18-000002 · primary_doc.xml · derivative · entry 1 LAU Tsz Ho Tony · CIK 0001714259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2023-07-26 F1 · derivative.exercise_date: The stock options vest in three equal annual installments commencing on July 26, 2019. Read SEC document |
| June 22, 2018 Filed Jun 26, 2018 17:19 UTC | Niagen Bioscience, Inc. CDXC · Entity 6146 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0001415889-18-001035 · form4-06262018_020646.xml · derivative · entry 1 LAU Tsz Ho Tony · CIK 0001714259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-06-22 F1 · derivative.exercise_date: Options vest 100% on June 22, 2019. Read SEC document |
| August 18, 2017 Filed Aug 21, 2017 16:25 UTC | Niagen Bioscience, Inc. CDXC · Entity 6146 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $3.28 | $0.00 |
DisclosureSEC source: 0001209191-17-049708 · doc4.xml · derivative · entry 1 LAU Tsz Ho Tony · CIK 0001714259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-08-17 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on August 18, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.